Literature DB >> 24676384

Tryptophan as the fingerprint for distinguishing aggressiveness among breast cancer cell lines using native fluorescence spectroscopy.

Lin Zhang1, Yang Pu2, Jianpeng Xue3, Sebastião Pratavieira4, Baogang Xu3, Samuel Achilefu3, Robert R Alfano2.   

Abstract

Tryptophan is investigated as the key native marker in cells to determine the level of metastasis competence in breast cell lines using native fluorescence spectroscopy. The ratio of fluorescence intensity at 340 nm to intensity at 460 nm is associated with aggressiveness of the cancer cells. We found that the fluorescence of aggressive breast cancer cell has a much higher contribution from tryptophan compared with that from the normal cells and nonaggressive breast cancer cell.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24676384     DOI: 10.1117/1.JBO.19.3.037005

Source DB:  PubMed          Journal:  J Biomed Opt        ISSN: 1083-3668            Impact factor:   3.170


  5 in total

1.  Monitoring Breast Cancer Response to Treatment Using Stokes Shift Spectroscopy of Blood Plasma.

Authors:  Krishnamoorthy Chithra; Prakasarao Aruna; Gnanatheepam Einstein; Srinivasan Vijayaraghavan; Singaravelu Ganesan
Journal:  J Fluoresc       Date:  2019-06-12       Impact factor: 2.217

2.  Evaluation of Antitumor Activity of Hesperetin-Loaded Nanoparticles Against DMBA-Induced Oral Carcinogenesis Based on Tissue Autofluorescence Spectroscopy and Multivariate Analysis.

Authors:  Krishnamoorthy Gurushankar; Shaiju S Nazeer; Ramapurath S Jayasree; Narendran Krishnakumar
Journal:  J Fluoresc       Date:  2015-05-07       Impact factor: 2.217

3.  The therapy of gefitinib towards breast cancer partially through reversing breast cancer biomarker arginine.

Authors:  Dongmei Geng; Dengjun Sun; Liangming Zhang; Weiwei Zhang
Journal:  Afr Health Sci       Date:  2015-06       Impact factor: 0.927

4.  Strong Dependence between Tryptophan-Related Fluorescence of Urine and Malignant Melanoma.

Authors:  Anna Birková; Marcela Valko-Rokytovská; Beáta Hubková; Marianna Zábavníková; Mária Mareková
Journal:  Int J Mol Sci       Date:  2021-02-13       Impact factor: 5.923

Review 5.  The relevance of tyrosine kinase inhibitors for global metabolic pathways in cancer.

Authors:  Michaela Poliaková; Daniel M Aebersold; Yitzhak Zimmer; Michaela Medová
Journal:  Mol Cancer       Date:  2018-02-19       Impact factor: 27.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.